甲状腺癌131I治疗后胆囊及高级别浆液性卵巢腺癌异常摄取一例
一例55岁女性甲状腺乳头状癌患者在接受全甲状腺切除及3程131I治疗后,第三次治疗后全身扫描显示右上腹(与肝脏重叠)及盆腔异常131I摄取,SPECT/CT定位为增大的胆囊和盆腔囊实性肿块,病理证实为双侧高级别浆液性卵巢腺癌。
要点
- 甲状腺癌131I治疗后扫描中胆囊和卵巢腺癌摄取131I属罕见。
- SPECT/CT有助于定位131I异常摄取灶并鉴别生理性与病理性。
- 盆腔囊实性肿块伴131I摄取时需警惕卵巢来源肿瘤。
核心结论
- 甲状腺癌患者131I治疗后扫描可出现胆囊及高级别浆液性卵巢腺癌的异常131I摄取。
研究设计与样本
- 个案报道:一例55岁女性甲状腺乳头状癌患者,接受全甲状腺切除及3程131I治疗。
主要发现
- 第三次131I治疗后全身扫描显示右上腹(与肝脏重叠)及盆腔异常131I摄取。
- 进一步SPECT/CT显示摄取来自增大的胆囊和盆腔巨大囊实性肿块。
- 盆腔肿块病理证实为双侧高级别浆液性卵巢腺癌。
局限性
- 原文未述局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
It is unusual to observe I accumulation in the gallbladder and high-grade serous ovarian adenocarcinoma during posttherapeutic I scan. We report the case of a 55-year-old woman with papillary thyroid cancer, who received total thyroidectomy and then 3 courses of I therapy. The posttherapeutic whole-body scan after the third dose of I therapy revealed abnormal I uptake in the right upper abdomen, overlapping the liver, and the pelvis. Further SPECT/CT imaging found that they were from an enlarged gallbladder and a large pelvic complex solid and cystic mass, which was pathologically confirmed as bilateral high-grade serous ovarian adenocarcinoma.
引用
- Yao X, Wang J, Xia M, et al. Increased 131I Accumulation in the Gallbladder and High-grade Serous Ovarian Adenocarcinoma. Clin Nucl Med. 2019. PMID: 30371583. doi:10.1097/RLU.0000000000002339
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。